Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine

British Journal of Cancer

Volumn 109, Issue 11, 2013, Pages 2810-2818

  Bijian, K ^a   Lougheed, C ^a   Su, J ^a   Xu, B ^a   Yu, H ^a   Wu, J H ^a   Riccio, K ^a   Alaoui Jamali, M A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FOCAL ADHESION KINASE; PACLITAXEL; PURINE DERIVATIVE; REVERSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER MODEL; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING SITE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME INHIBITION; FEMALE; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MEMBRANE STRUCTURE; METASTASIS INHIBITION; MOLECULAR DOCKING; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TURNOVER TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELLS, CULTURED; FEMALE; FOCAL ADHESIONS; HUMANS; MCF-7 CELLS; MICE; MICE, SCID; MOLECULAR TARGETED THERAPY; MORPHOLINES; PURINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84888880765     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.675     Document Type: Article

References (39)

1. Alaoui-Jamali MA, Song DJ, Benlimame N, Yen L, Deng X, Hernandez-Perez M, Wang T (2003) Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors. Cancer Res 63: 3764-3774. (Pubitemid 36793065)
2. Behmoaram E, Bijian K, Jie S, Xu Y, Darnel A, Bismar TA, Alaoui-Jamali MA (2008) Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Am J Pathol 173: 1540-1550.
3. Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M, Schlaepfer DD, Alaoui-Jamali MA (2005) FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J Cell Biol 171: 505-516. (Pubitemid 41586939)
4. Chan KT, Cortesio CL, Huttenlocher A (2009) FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol 185: 357-370.
5. Chen S, Takanashi S, Zhang Q, Xiong W, Zhu S, Peters EC, Ding S, Schultz PG (2007) Reversine increases the plasticity of lineage-committed mammalian cells. Proc Natl Acad Sci USA 104: 10482-10487. (Pubitemid 47185691)
6. Chen S, Zhang Q, Wu X, Schultz PG, Ding S (2004) Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126: 410-411. (Pubitemid 38084591)
7. D'alise AM, Amabile G, Iovino M, Di Giorgio FP, Bartiromo M, Sessa F, Villa F, Musacchio A, Cortese R (2008) Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Mol Cancer Ther 7: 1140-1149.
8. Ezratty EJ, Partridge MA, Gundersen GG (2005) Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat Cell Biol 7: 581-590. (Pubitemid 40796981)
9. Geiger B, Bershadsky A (2001) Assembly and mechanosensory function of focal contacts. Curr Opin Cell Biol 13: 584-592. (Pubitemid 32817017)
10. Geiger B, Spatz JP, Bershadsky AD (2009) Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol 10: 21-33.
11. Hsieh TC, Traganos F, Darzynkiewicz Z, Wu JM (2007) The 2,6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells. Int J Oncol 31: 1293-1300.
12. Hua SC, Chang TC, Chen HR, Lu CH, Liu YW, Chen SH, Yu HI, Chang YP, Lee YR (2012) Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells. Pharm Res 29: 1990-2005.
13. Kim YK, Choi HY, Kim NH, Lee W, Seo DW, Kang DW, Lee HY, Han JW, Park SW, Kim SN (2007) Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells. Biochem Biophys Res Commun 358: 553-558. (Pubitemid 46755739)
14. Kuo CH, Lu YC, Tseng YS, Shi CS, Chen SH, Chen PT, Wu FL, Chang YP, Lee YR (2012) Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells. Breast Cancer; e-pub ahead of print 28 August 2012; doi:10.1007/s12282-012-0400-z.
15. Lee YR, Wu WC, Ji WT, Chen JY, Cheng YP, Chiang MK, Chen HR (2012) Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy. J Biomed Sci 19: 9.
16. Liotta LA, Kohn E (2004) Anoikis: cancer and the homeless cell. Nature 430: 973-974.
17. Lopez-Knowles E, O'toole SA, Mcneil CM, Millar EK, Qiu MR, Crea P, Daly RJ, Musgrove EA, Sutherland RL (2010) PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int J Cancer 126: 1121-1131.
18. Lu CH, Liu YW, Hua SC, Yu HI, Chang YP, Lee YR (2012) Autophagy induction of reversine on human follicular thyroid cancer cells. Biomed Pharmacother 66: 642-647.
19. Luo M, Guan JL (2010) Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 289: 127-139.
20. Mcmillin DW, Delmore J, Weisberg E, Negri JM, Geer DC, Klippel S, Mitsiades N, Schlossman RL, Munshi NC, Kung AL, Griffin JD, Richardson PG, Anderson KC, Mitsiades CS (2010) Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med 16: 483-489.
21. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68. (Pubitemid 40064899)
22. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516-523. (Pubitemid 44332916)
23. Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395. (Pubitemid 34214843)
24. Nissink JW, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R (2002) A new test set for validating predictions of protein-ligand interaction. Proteins 49: 457-471. (Pubitemid 35388132)
25. Perreira M, Jiang JK, Klutz AM, Gao ZG, Shainberg A, Lu C, Thomas CJ, Jacobson KA (2005) 'Reversine' and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 48: 4910-4918. (Pubitemid 41033133)
26. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003) Cell migration: integrating signals from front to back. Science 302: 1704-1709. (Pubitemid 37505725)
27. Santaguida S, Tighe A, D'alise AM, Taylor SS, Musacchio A (2010) Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine. J Cell Biol 190: 73-87.
28. Schaller MD (2001) Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20: 6459-6472. (Pubitemid 32977851)
29. Sein TT, Thant AA, Hiraiwa Y, Amin AR, Sohara Y, Liu Y, Matsuda S, Yamamoto T, Hamaguchi M (2000) A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and-9. Oncogene 19: 5539-5542. (Pubitemid 32000922)
30. Shan SW, Tang MK, Chow PH, Maroto M, Cai DQ, Lee KK (2007) Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types. Proteomics 7: 4303-4316. (Pubitemid 350250475)
31. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD (2000) FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249-256.
32. Siesser PM, Hanks SK (2006) The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 12: 3233-3237.
33. Wehrle-Haller B (2012) Assembly and disassembly of cell matrix adhesions. Curr Opin Cell Biol 24: 569-581.
34. Xu Y, Benlimame N, Su J, He Q, Alaoui-Jamali MA (2009) Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells. Br J Cancer 100: 633-643.
35. Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R, Alaoui-Jamali MA (2010) Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J Exp Med 207: 2421-2437.
36. Yen L, Benlimame N, Nie ZR, Xiao D, Wang T, Al Moustafa AE, Esumi H, Milanini J, Hynes NE, Pages G, Alaoui-Jamali MA (2002) Differential regulation of tumor angiogenesis by distinct ErbB homo-and heterodimers. Mol Biol Cell 13: 4029-4044. (Pubitemid 35398568)
37. Yeo MG, Partridge MA, Ezratty EJ, Shen Q, Gundersen GG, Marcantonio EE (2006) Src SH2 arginine 175 is required for cell motility: specific focal adhesion kinase targeting and focal adhesion assembly function. Mol Cell Biol 26: 4399-4409. (Pubitemid 43877562)
38. Zaidel-Bar R, Ballestrem C, Kam Z, Geiger B (2003) Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J Cell Sci 116: 4605-4613. (Pubitemid 37461615)
39. Zaidel-Bar R, Itzkovitz S, Ma'ayan A, Iyengar R, Geiger B (2007) Functional atlas of the integrin adhesome. Nat Cell Biol 9: 858-867. (Pubitemid 47190436)